Basel Medical Group Ltd
Close on Oct 19, 2026
About Basel Medical
Services-Offices & Clinics of Doctors of Medicine, SIC 8011
Basel Medical Group Ltd provides healthcare services specializing in orthopedic medical care and related treatments. Through its medical clinics and operational entities, the group offers medical consultations, orthopedic procedures, physiotherapy, and healthcare services focused on musculoskeletal conditions, sports injuries, and knee disorders. Its clinical services cater to individual patients requiring orthopedic diagnosis and treatment, as well as corporate clients that refer patient volume to the group's facilities.
The company conducts its clinical operations through medical facilities located in Singapore, including clinics based at Gleneagles Medical Centre. It operates specialized clinics and service units such as Singapore Sports and Orthopaedic Clinic and Singapore Knee, Sports and Orthopaedic Clinic. Basel Medical Group is incorporated in the British Virgin Islands and maintains its principal executive offices and headquarters in Singapore.
Summary of the business section of Basel Medical's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Basel Medical Group Ltd
- Headquarters
- Singapore, U0
- Address
- 600 North Bridge Road, #12-02/03, Parkview Square 188778
- Phone
- (656) 291-9188
- Employees
- 36, Jun 30, 2025
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- Incorporated in
- D8
- Fiscal year ends
- June 30
- Auditor
- NLA DFK Assurance PAC, Singapore
Stock & identifiers
- Ticker
- BMGL
- Exchange
- Nasdaq
- IPO date
- Feb 25, 2025
- Shares outstanding
- 19M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-12 reverse, Jun 22, 2026
- SEC CIK
- 2004489
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Boon Chye Tan | Chief Commercial Officer, Director | 10,205,229 |
| Alton Chun How Neo | Interim CFO | – |
| Jianing JN Lu | Chief Financial Officer | – |
| Darren Yen Feng Chhoa | Chief Executive Officer | – |
| Kwek Yoon Soong | Director | – |
| Tony Chen | Director | – |
| Keng Leong Fung | Director | 10,205,229 |
| Paul D. Freudenthaler | Director | – |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 27, 2025 | Late filing | Notification of late filing |
| Feb 25, 2025 | IPO | Initial public offering priced (424B4 prospectus) |
| Feb 14, 2025 | Listing | Registration of securities on an exchange (Form 8-A) |